Christopher Lowery - Owens Minor President - Global Products
OMI Stock | USD 13.27 0.36 2.64% |
President
Mr. Christopher M. Lowery is President Global Products of the Company since January 2018 since 2018.
Age | 57 |
Tenure | 6 years |
Phone | 804 723 7000 |
Web | https://www.owens-minor.com |
Owens Minor Management Efficiency
The company has Return on Asset of 0.0402 % which means that on every $100 spent on assets, it made $0.0402 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.0554) %, meaning that it generated no profit with money invested by stockholders. Owens Minor's management efficiency ratios could be used to measure how well Owens Minor manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | PRESIDENT Age | ||
Steve Cunningham | Patterson Companies | N/A | |
Lori Schechter | McKesson | 58 | |
Michael Pintek | Cardinal Health | 55 | |
Brian Rice | Cardinal Health | 57 | |
Britt Vitalone | McKesson | 54 | |
Paul Guggenheim | Patterson Companies | 64 | |
James CPA | Henry Schein | 70 | |
David Wilson | Cardinal Health | N/A | |
John Wright | Patterson Companies | N/A | |
Les Korsh | Patterson Companies | 54 | |
Jorge Sahlieh | Cardinal Health | N/A | |
Nancy Flores | McKesson | 54 | |
George Henriques | Patterson Companies | 64 | |
Kristin Dietzler | Patterson Companies | N/A | |
Patricia CPA | Cardinal Health | 44 | |
Timothy Rogan | Patterson Companies | 52 | |
Donald Gregg | Zynex Inc | N/A | |
Rob Schlissberg | Cardinal Health | N/A | |
Ben Brinker | Cardinal Health | N/A | |
Michele Holcomb | Cardinal Health | 52 | |
Kirk Kaminsky | McKesson | N/A |
Management Performance
Return On Equity | -0.0554 | ||||
Return On Asset | 0.0402 |
Owens Minor Leadership Team
Elected by the shareholders, the Owens Minor's board of directors comprises two types of representatives: Owens Minor inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Owens. The board's role is to monitor Owens Minor's management team and ensure that shareholders' interests are well served. Owens Minor's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Owens Minor's outside directors are responsible for providing unbiased perspectives on the board's policies.
Christopher Lowery, President - Global Products | ||
Snehashish Sarkar, Executive Officer | ||
Jennifer Stone, Executive Officer | ||
Alex CPA, Director Relations | ||
Jeffrey Jochims, Executive Vice President, Chief Operating Officer, President - Products and Healthcare Services | ||
Shana Neal, Chief Human Resource Officer, Executive Vice President | ||
Aster Angagaw, Independent Director | ||
Tammy Gomez, Ex Officer | ||
Michael Riordan, Independent Director | ||
Trudi Allcott, Director Relations | ||
Stephen Klemash, Independent Director | ||
Edward Pesicka, President, Chief Executive Officer, Director | ||
Michael Lowry, Interim Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Corporate Controller | ||
Robert Henkel, Independent Director | ||
Gwendolyn Bingham, Independent Director | ||
Alexander Bruni, Executive Officer | ||
Kenneth Smith, Independent Director | ||
Andrew Long, Chief Financial Officer, Executive Vice President | ||
Daniel Starck, Executive Excellence | ||
Mark Zacur, Executive Vice President, Chief Commercial Officer | ||
Heath Galloway, General VP | ||
Robert Sledd, Independent Chairman of the Board | ||
Jonathan Leon, Senior Vice President Corporate Treasurer | ||
Eddie Moore, Independent Director | ||
Kenny Gardner, Director | ||
David Myers, Senior Vice President Chief Procurement Officer | ||
Mark Beck, Independent Chairman of the Board | ||
Nicholas II, Gen VP | ||
Nicholas Pace, Executive Vice President, General Counsel, Corporate Secretary | ||
Perry Bernocchi, Executive Segment | ||
Mark McGettrick, Independent Director |
Owens Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Owens Minor a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.0554 | ||||
Return On Asset | 0.0402 | ||||
Profit Margin | (0) % | ||||
Operating Margin | 0.02 % | ||||
Current Valuation | 3.2 B | ||||
Shares Outstanding | 77.11 M | ||||
Shares Owned By Insiders | 2.43 % | ||||
Shares Owned By Institutions | 97.57 % | ||||
Number Of Shares Shorted | 3.95 M | ||||
Price To Earning | 42.00 X |
Currently Active Assets on Macroaxis
When determining whether Owens Minor offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Owens Minor's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Owens Minor Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Owens Minor Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Owens Minor. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For more detail on how to invest in Owens Stock please use our How to Invest in Owens Minor guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Owens Minor. If investors know Owens will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Owens Minor listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Owens Minor is measured differently than its book value, which is the value of Owens that is recorded on the company's balance sheet. Investors also form their own opinion of Owens Minor's value that differs from its market value or its book value, called intrinsic value, which is Owens Minor's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Owens Minor's market value can be influenced by many factors that don't directly affect Owens Minor's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Owens Minor's value and its price as these two are different measures arrived at by different means. Investors typically determine if Owens Minor is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Owens Minor's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.